php Courses

Nov 15, 2023 · Artificial Intelligence

AI-Discovered Drug for Idiopathic Pulmonary Fibrosis Enters Late-Stage Clinical Trials

Insilico Medicine, leveraging artificial intelligence to identify a novel target and molecule for idiopathic pulmonary fibrosis, has advanced its AI-discovered drug into late-stage clinical trials, marking the first fully AI-generated pre-clinical candidate and drawing significant attention from the pharmaceutical industry.